René Charlotte A, Parks Robin J
Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada.
Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, ON K1N 65N, Canada.
Pharmaceutics. 2021 Apr 3;13(4):492. doi: 10.3390/pharmaceutics13040492.
The central nervous system (CNS) is surrounded by the blood-brain barrier (BBB), a semipermeable border of endothelial cells that prevents pathogens, solutes and most molecules from non-selectively crossing into the CNS. Thus, the BBB acts to protect the CNS from potentially deleterious insults. Unfortunately, the BBB also frequently presents a significant barrier to therapies, impeding passage of drugs and biologicals to target cells within the CNS. This review provides an overview of different approaches to deliver therapeutics across the BBB, with an emphasis in extracellular vesicles as delivery vehicles to the CNS.
中枢神经系统(CNS)被血脑屏障(BBB)所包围,血脑屏障是由内皮细胞构成的半透性边界,可防止病原体、溶质和大多数分子非选择性地进入中枢神经系统。因此,血脑屏障起到保护中枢神经系统免受潜在有害损伤的作用。不幸的是,血脑屏障也常常对治疗构成重大障碍,阻碍药物和生物制剂进入中枢神经系统内的靶细胞。本综述概述了跨越血脑屏障递送治疗药物的不同方法,重点介绍了细胞外囊泡作为向中枢神经系统递送载体的情况。